Controlling content uniformity is crucial for pharmaceutical manufacturers. Generally, HPLC (high performance liquid chromatography) is used, though it requires intensive manual sample preparation and incurs high costs. Near-infrared spectroscopy (NIRS) offers users quick, reagent-free analysis, reducing time and expenses for dosage uniformity tests. This Application Note demonstrates the determination of active pharmaceutical ingredient (API) content in ceftazidime tablets with NIRS, showing that this method can also be used to assess excipient content.
